JISHANYE, INC. (JSHY) financial statements (2021 and earlier)
Company profile
| Business Address |
7F., NO.247, MINSHENG 1ST RD. KAOHSIUNG CITY, 800 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 1,041 | 12 | 4 | ||
| Cash and cash equivalents | 1,041 | 12 | 4 | ||
| Inventory, net of allowances, customer advances and progress billings | 5 | 1 | ✕ | ||
| Inventory | 5 | 1 | |||
| Prepaid expense | 10 | 2 | |||
| Other undisclosed current assets | 1 | 8 | |||
| Total current assets: | 1,058 | 15 | 12 | ||
| Noncurrent Assets | |||||
| Property, plant and equipment | 27 | ||||
| Deposits noncurrent assets | 10 | ||||
| Total noncurrent assets: | 10 | 27 | |||
| TOTAL ASSETS: | 1,067 | 15 | 39 | ||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 96 | 115 | 0 | ||
| Accounts payable | 114 | 0 | |||
| Accrued liabilities | 69 | 1 | |||
| Employee-related liabilities | 26 | ||||
| Debt | 39 | ||||
| Due to related parties | 455 | 159 | |||
| Other undisclosed current liabilities | 18 | 113 | |||
| Total current liabilities: | 569 | 274 | 152 | ||
| Noncurrent Liabilities | |||||
| Total liabilities: | 569 | 274 | 152 | ||
| Stockholders' equity | |||||
| Stockholders' equity attributable to parent | 498 | (259) | (113) | ||
| Common stock | 6 | 1 | 1 | ||
| Additional paid in capital | 1,093 | 99 | 99 | ||
| Accumulated other comprehensive income (loss) | 6 | (0) | 0 | ||
| Accumulated deficit | (607) | (359) | (213) | ||
| Total stockholders' equity: | 498 | (259) | (113) | ||
| TOTAL LIABILITIES AND EQUITY: | 1,067 | 15 | 39 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|
| Revenues | 204 | 18 | 25 | |
| Cost of revenue | (171) | (1) | (10) | |
| Gross profit: | 33 | 17 | 15 | |
| Operating expenses | (286) | (162) | (185) | |
| Other operating expense, net (Other Expenses) | (1) | |||
| Other undisclosed operating income | 1 | |||
| Operating loss: | (253) | (144) | (170) | |
| Nonoperating income (expense) | 4 | (1) | (1) | |
| Other nonoperating income (expense) | 4 | (1) | ||
| Net loss available to common stockholders, diluted: | (249) | (146) | (171) | |
Comprehensive Income ($ in thousands)
| 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|
| Net loss: | (249) | (146) | (171) | |
| Other comprehensive loss | (242) | (146) | (173) | |
| Comprehensive loss, net of tax, attributable to parent: | (491) | (292) | (344) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.